Filing Details

Accession Number:
0001209191-14-043947
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-26 19:50:28
Reporting Period:
2014-06-24
Filing Date:
2014-06-26
Accepted Time:
2014-06-26 19:50:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378166 David Young 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-24 6,000 $4.54 117,741 No 4 M Direct
Common Stock Disposition 2014-06-24 6,000 $91.96 117,741 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-06-24 6,000 $0.00 6,000 $4.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
71,000 2019-10-29 No 4 M Direct
Footnotes
  1. Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on 10/30/2009.
  2. The option was granted on 10/30/2009 for the right to buy 350,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant with a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
  3. The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $91.53 - $92.14. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form